Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization.
about
Self-assembling protein nanoparticles in the design of vaccinesThe C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host InteractionCross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron MicroscopyA human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5Naturally Occurring Major and Minor Capsid Protein Variants of Human Papillomavirus 45 (HPV45): Differential Recognition by Cross-Neutralizing Antibodies Generated by HPV Vaccines.L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis.The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies.Functional assessment and structural basis of antibody binding to human papillomavirus capsid.Human papillomavirus major capsid protein L1 remains associated with the incoming viral genome throughout the entry process.Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human PapillomavirusNaturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization.High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36.
P2860
Q26767097-967AA9D9-9EA3-464E-ACA3-18C2D4DF95BCQ27709061-796B0D65-E663-4F02-8B23-6E86C436091FQ30353668-3AF7F132-8AD3-4388-8623-B57C6799DCBAQ36281141-C2C939A5-7513-4A21-A7F9-5D3B5FE5A6D6Q36448778-4E9D0B77-AE87-4BC6-9E42-D7EAC9A569E6Q36736614-0FE40066-1646-4A2F-8142-6B60AFCAC2D4Q37322176-572EE575-EF30-46C9-85D5-5840C506414EQ37526148-9869ADC4-B812-4CA9-AD7D-C4FBACA1DAE6Q38671633-B2932318-5E9A-46CD-92C7-46F1FD755A72Q38752656-2D634F61-43FD-41D1-9790-F7DD48DBA101Q41676237-73318DE2-3B1D-4F23-8B2D-7AE8DB641943Q41926483-7CF45CAC-6073-4DD7-B8E9-55E1DEFA0AE5Q47136931-E07B64EF-3E32-4CF4-980E-20D42E659E51Q47143249-9EB22FB5-430B-4AA0-8CBB-828DD5C27AC6
P2860
Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Structural comparison of four ...... mechanisms of neutralization.
@en
type
label
Structural comparison of four ...... mechanisms of neutralization.
@en
prefLabel
Structural comparison of four ...... mechanisms of neutralization.
@en
P2093
P2860
P1433
P1476
Structural comparison of four ...... mechanisms of neutralization.
@en
P2093
Alexander M Makhov
Hyunwook Lee
James F Conway
Neil D Christensen
Robert E Ashley
Sarah A Brendle
Stephanie M Bywaters
P2860
P304
P356
10.1016/J.VIROL.2015.04.016
P407
P577
2015-05-19T00:00:00Z